Atlas Trials

Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients

Clinical trial NCT07715929 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07715929
Sponsor
Yunlong Wang
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial FibrillationObesity & OverweightCatheter Ablation
Start date
2026-09-01
Primary completion
2029-09-01
Enrollment
710

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.